World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
62
Citations
16446
World Ranking
3213
National Ranking
17

Overview

Pierre-Michel Llorca is affiliated with the University of Clermont Auvergne in France. Their research spans multiple fields within medicine and psychology, with a focus on psychiatry and mental health as well as clinical psychology. The work also touches on pharmacology, social psychology, and experimental and cognitive psychology.

The scientist's research topics include schizophrenia research and treatment, bipolar disorder and treatment, and the treatment of major depression. Other significant areas include tryptophan and brain disorders, mental health treatment and access, COVID-19 and mental health, and child and adolescent psychosocial and emotional development.

Pierre-Michel Llorca has contributed to several recent papers, including:

  • Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review (2020, L Encéphale)
  • Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries (2021, JAMA Psychiatry)
  • Assurer les soins aux patients souffrant de troubles psychiques en France pendant l'épidémie à SARS-CoV-2 (2020, L Encéphale)
  • Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial (2022, BMJ)
  • Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression (2023, New England Journal of Medicine)

Their frequent co-authors include:

  • Marion Leboyer
  • Guillaume Fond
  • Caroline Dubertret
  • Émmanuel Haffen
  • Philippe Courtet

Publication venues commonly featuring their work are:

  • Psychological Medicine
  • European Psychiatry
  • L Encéphale
  • Journal of Affective Disorders
  • Schizophrenia Bulletin

Pierre-Michel Llorca's extensive publication record reflects a sustained engagement with key topics in mental health research, particularly related to severe psychiatric conditions and emerging challenges such as the mental health impact of COVID-19.

Best Publications

  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

    Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

  • Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

    W Wolfgang Fleischhacker;Mariëlle Eerdekens;Keith Karcher;Gary Remington

  • Assessment and management of agitation in psychiatry: Expert consensus

    Marina Garriga;Isabella Pacchiarotti;Siegfried Kasper;Scott L Zeller

  • Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

    Jim van Os;Jim van Os;Bart P. Rutten;Inez Myin-Germeys;Philippe Delespaul

  • Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study.

    Hannah Jongsma;Charlotte Gayer-Anderson;Antonio Lasalvia;Diego Quattrone

  • Diagnostic criteria for apathy in clinical practice

    E. Mulin;E. Leone;K. Dujardin;M. Delliaux

  • Assurer les soins aux patients souffrant de troubles psychiques en France pendant l'épidémie à SARS-CoV-2./ [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].

    A Chevance;D Gourion;N Hoertel;P-M Llorca

  • Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.

    A. Chevance;D. Gourion;N. Hoertel;P.-M. Llorca

  • Partial compliance in schizophrenia and the impact on patient outcomes

    Pierre-Michel Llorca

  • Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis.

    Guillaume Fond;Katlyn Nemani;Damien Etchecopar-Etchart;Anderson Loundou

  • Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.

    Pierre Michel Llorca;Mocrane Abbar;Philippe Courtet;Sebastien Guillaume

  • Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.

    Philippe Damier;Stéphane Thobois;Tatiana Witjas;Emmanuel Cuny

  • Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

    P. P. Derost;L. Ouchchane;D. Morand;M. Ulla

  • COVID-19 pandemic lockdown and problematic eating behaviors in a student population

    Valentin Flaudias;Sylvain Iceta;Sylvain Iceta;Oulmann Zerhouni;Rachel F. Rodgers;Rachel F. Rodgers

  • Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.

    Pierre-Michel Llorca;Christian Spadone;Olivier Sol;Anne Danniau

  • Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.

    Hani-Jürgen Möller;Pierre-Michel Llorca;Emilio Sacchetti;Stephen D. Martin

  • Psychopathological features of a patient population of targets of workplace bullying

    Georges Brousse;Luc Fontana;Lemlih Ouchchane;Caroline Boisson

  • The Functional Remission of General Schizophrenia (FROGS) scale: Development and validation of a new questionnaire

    Pierre-Michel Llorca;Christophe Lançon;Sylvie Lancrenon;Franck-Jean Bayle

  • Risk factors for treatment resistance in unipolar depression: a systematic review.

    D. Bennabi;B. Aouizerate;W. El-Hage;O. Doumy

  • [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].

    D Misdrahi;P M Llorca;C Lançon;F J Bayle

  • Tardive dyskinesias and antipsychotics: a review.

    Pierre-Michel Llorca;Isabelle Chereau;Frank-Jean Bayle;Christophe Lancon

  • A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia.

    Thierry d'Amato;Remy Bation;Alain Cochet;Isabelle Jalenques

Frequent Co-Authors

Marion Leboyer
Marion Leboyer Paris-Est Créteil University
Christophe Lançon
Christophe Lançon Aix-Marseille University
Christine Passerieux
Christine Passerieux Versailles Saint-Quentin-en-Yvelines University
Julio Bobes
Julio Bobes University of Oviedo
Miguel Bernardo
Miguel Bernardo University of Barcelona
Marta Di Forti
Marta Di Forti King's College London
Celso Arango
Celso Arango Complutense University of Madrid
Philip Gorwood
Philip Gorwood Université Paris Cité
Sébastien Guillaume
Sébastien Guillaume University of Montpellier
Eduard Vieta
Eduard Vieta University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Psychology in the USA opens up a variety of online degrees and professional opportunities. Online counseling and psychology programs now offer greater flexibility for students, and choosing a reputable program is crucial to prepare for licensure and specialized fields.

Many top institutions provide specialized counseling tracks, from clinical to school counseling, to meet the needs of today’s job market. Those interested in gaining insight into regional options might explore the best college counseling programs in Stockton, compare options among the best counseling degree programs in Tucson, or discover robust opportunities within the best counseling degree programs in Texas.

Additionally, students who wish to work in the Pacific Northwest may benefit from researching the best college counseling programs in Washington. By selecting an accredited program and understanding licensure requirements, graduates can pursue roles such as licensed professional counselor, school counselor, or mental health advocate—all in high demand nationwide.

Best Scientists Citing Pierre-Michel Llorca

Trending Scientists